BASF stock
BAS.DEXETRABASF SE, Basic MaterialsISIN DE000BASF111WKN BASF11
54Score 54 out of 100, Neutral
Price and trend
81 / 100
Price history
+24% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 7.2% above it.
Since January 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 63).
The price is 2.9% below its 52-week high. Largest decline in 20 years: 62% (January 2008 to October 2008).
Chart figures for advanced users
- SMA 50$58.27
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$56.54
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)63
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$46.62
- The lowest closing price of the last twelve months.
- Resistance$62.41
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- BASF SE belongs to the Chemicals industry (Germany) and, with a market value of $52.24B, is number 3 of 44 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $66.38B (down 2.9% year on year) and earnings of $1.8B (up 24.7%).
- For fiscal 2026, analysts expect on average revenue of $71.35B (up 7.5%) and adjusted earnings per share of $3.61 (up 25.6%).
Show more
- MEQIRI Score 54 out of 100 (Neutral): rank 278 of 467 in Basic Materials, median 58.
- Our model puts fair value at $36.69, with the price 65% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- Above fair valuePrice 65% above the fair value of $36.69.Valuation 29
Its standout strengths are technical analysis and stability, while growth and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among stocks ranked 101 to 1,000.
From 2016 to 2025, 13 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- calm price action
- price near its 52-week high
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $30.58 and expensive above $45.87 (uncertainty low, based on the price swings of the past year).
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $29.23, at 6.1% it would be $47.97.
Valuation metrics
From the cash-flow model alone; the profit includes one-off items, so there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 2% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 24%, operating 4%, net 3%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 26 Feb 2027in 106 days
- Last reported
- 28 Oct 2026EPS reported $0.81 (expected $0.45)above expectations
Analyst estimates
Analysts have raised their 2026 earnings estimate by 3.5% since 15 Oct 2026.
- Earnings per share
- $3.61+3.5%
- Revenue
- $71.35B+0.9%
- Earnings per share
- $3.34+0.1%
- Revenue
- $72.76B+1.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +1.4%BASF raised its 2026 EBITDA before special items forecast to a range of 7.4 to 7.8 billion euros and now expects capital spending to come in clearly below 3 billion euros instead of 3.4 billion, while keeping the free cash flow target unchanged at 1.5 to 2.3 billion euros.
“For the full year 2026, we now expect payments made for property, plant and equipment and intangible assets to come in clearly below EUR 3 billion compared with the forecast of EUR 3.4 billion provided in February 2026.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 28 Oct 2026 (fiscal Q3 2026), read by AI.
What happened at BASF
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 54
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Nan Ya Plastics1303.TW $75.57B55
- Shin-Etsu Chemical4063.T $65.1B72
- DowDOW $23.56B43
- Ningxia Baofeng Energy Group600989.SS $23.06B74
- DuPont de NemoursDD $20.62B50
- Rongsheng Petrochemical002493.SZ $17.48B52
- Hengli Petrochemical600346.SS $17.34B50
- Zangge Mining000408.SZ $15.41B72
ETFs that hold BASF
Held by 145 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares STOXX Europe 600 Chemicals UCITS ETF (DE)EXV7 | 14.14% | 0.46% | €114.14M |
| iShares DivDAX UCITS ETF (DE)EXSB | 8.39% | 0.31% | €566.09M |
| State Street SPDR MSCI Europe Materials UCITS ETFSPYP | 7.18% | 0.18% | €109.81M |
Show 5 more
| Xtrackers MSCI Europe Materials Screened UCITS ETF 1CDXSC | 6.89% | 0.17% | €66.76M |
| Deka DAX ex Financials 30 UCITS ETFELF0 | 4.65% | 0.31% | €19.34M |
| Amundi DAX 50 ESG II UCITS ETF DistE909 | 4.32% | 0.15% | €323.69M |
| Xtrackers DAX ESG Screened UCITS ETF 1DXDDX | 4.30% | 0.09% | €591.73M |
| Xtrackers DAX UCITS ETF 1CDBXD | 2.77% | 0.09% | €7.32B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.